Results 251 to 260 of about 332,163 (305)

From Metabolic Crisis to Molecular Classification: Multidisciplinary Management of Synchronous Endometrioid Ovarian and Endometrial Carcinomas With Massive Tumor Burden

Cancer Nexus, EarlyView.
Managing massive tumor burden in synchronous endometrioid carcinomas. The graphical abstract summarizes the clinical pathway from presentation with massive ascites, pleural effusion, and critical metabolic abnormalities to multidisciplinary stabilization, surgical management, integrated morphologic–molecular classification, and shared decision‐making ...
Anna Homeniuk, Leena Abdalla, Sharon Fitzgerald   +2 more
wiley   +1 more source

Neovascular Glaucoma Secondary to Choroidal Metastasis From Lung Adenocarcinoma: A Palliative Management Challenge. [PDF]

Cureus
Mohamad Kani NH, Lam C, Othman O.
europepmc   +1 more source

From Basics to Benchmarks: Evaluating Sample Adequacy, PD‐L1 Expression, and Molecular Profiling in Effusion Samples of Lung Adenocarcinoma

Diagnostic Cytopathology, EarlyView.
ABSTRACT Introduction Lung adenocarcinoma commonly causes malignant pleural effusion (MPE), a condition with poor prognosis and limited treatment options. Pleural effusion specimens offer a minimally invasive source for diagnosis and molecular testing.
Harpreet Virk, Claire Michael, Keri Ann Pfeil, Navid Sadri, Omid Savari, Aparna Harbhajanka   +5 more
wiley   +1 more source

CLWD: a Chinese histopathology dataset for lung adenocarcinoma subtype classification. [PDF]

Sci Data
Chen Y, Zhao H, Wang L, Li L, Liu R, Jiang Y, Tang P, Li Y, Ni J, Tao D, Li J, Peng J.   +11 more
europepmc   +1 more source

A comprehensive analysis of palmitoylation related genes in lung adenocarcinoma. [PDF]

Discov Oncol
Jiang J, Li Z, Yan T, He Y, Zhu J, Jin X, Rao S, Rao X.   +7 more
europepmc   +1 more source

Prognostic Effect of TTF-1 Expression and Histopathology in the Patients with Advanced Lung Adenocarcinoma Treated with Immunochemotherapy. [PDF]

Kobe J Med Sci
Iwamoto N, Yamada J, Jimbo N, Yamasaki N, Hatakeyama Y, Kiriu T, Matsumura K, Katsurada M, Okuno K, Nakata K, Tachihara M.   +10 more
europepmc   +1 more source

Amivantamab Monotherapy for Lung Adenocarcinoma With Leptomeningeal Seeding: A Case Report. [PDF]

Respirol Case Rep
Park K, Kim SY, Um SW.
europepmc   +1 more source

Ebracteolata cpd B causes ferroptosis and inhibits progression of lung adenocarcinoma. [PDF]

Front Pharmacol
Du Y, Han H, Dong Y, Yin X, Zhu J, Yin C, Wang H.   +6 more
europepmc   +1 more source

TSPAN32 as a biomarker associated with radiotherapy and immune microenvironment remodeling in lung adenocarcinoma. [PDF]

Front Oncol
Huang G, Hu H, Guo L, Xiao M, Chen W, Huang Y, Yang X, Li Z, Li X, Chen M, Huang X.   +10 more
europepmc   +1 more source